Everything by Chris.

Companies and Brands

Peloton’s Impressive Q2 Fails to Get Investors in Gear

Feb 5, 2020 Media

Are Q4 Earnings Twitter’s Time to Shine?

Feb 5, 2020 Companies and Brands

What to Expect When Peloton Reports After the Close

Feb 5, 2020 Companies and Brands

Casper Sleep Closes in on IPO: Should Investors Be Worried?

Feb 5, 2020 Health and Healthcare

Why This FDA Approval Is a Big Win for Vivus

Feb 5, 2020 Health and Healthcare

Is Merck Stuck in the Slow Lane?

Feb 5, 2020 Services

Are Chipotle Earnings Enough to Move The Needle?

Feb 4, 2020 Media

Snap Just Can’t Get It Together in Q4 Despite Bottom Line Beat

Feb 4, 2020 Media

Is Disney’s Q1 Really That Underwhelming?

Feb 4, 2020 Health and Healthcare

What to Expect When Merck Reports Before the Opening Bell

Feb 4, 2020 Services

Wendy’s Enters the Breakfast Battle

Feb 4, 2020 Cars and Drivers

Is There Any Way Ford and GM Can Catch Up to Tesla?

Feb 4, 2020 Media

Will Disney Deliver on Its Streaming Service?

Feb 4, 2020 Companies and Brands

Clorox Cleans Up in Q2, Expects Return to Growth

Feb 4, 2020 Technology

Alphabet’s Increased Transparency in Q4 Isn’t Enough For Investors

Feb 3, 2020 Cars and Drivers

Why One Analyst Believes This Is Just the Beginning for Tesla

Feb 3, 2020 Health and Healthcare

Insmed’s Bronchiectasis Study Is a Breath of Fresh Air for Investors

Feb 3, 2020 Health and Healthcare

Is the Coronavirus the Kick-Start Gilead Sciences Stock Needs?

Feb 3, 2020 Health and Healthcare

FDA Approves First-Ever Peanut Allergy Treatment

Feb 3, 2020 Investing

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

Feb 2, 2020